AIMC Topic: Drug Discovery

Clear Filters Showing 781 to 790 of 1558 articles

Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.

Molecular diversity
The accumulation of massive data in the plethora of Cheminformatics databases has made the role of big data and artificial intelligence (AI) indispensable in drug design. This has necessitated the development of newer algorithms and architectures to ...

CASTELO: clustered atom subtypes aided lead optimization-a combined machine learning and molecular modeling method.

BMC bioinformatics
BACKGROUND: Drug discovery is a multi-stage process that comprises two costly major steps: pre-clinical research and clinical trials. Among its stages, lead optimization easily consumes more than half of the pre-clinical budget. We propose a combined...

QSAR modeling without descriptors using graph convolutional neural networks: the case of mutagenicity prediction.

Molecular diversity
Deep neural networks are effective in learning directly from low-level encoded data without the need of feature extraction. This paper shows how QSAR models can be constructed from 2D molecular graphs without computing chemical descriptors. Two graph...

Drug repurposing: Iron in the fire for older drugs.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Repositioning or "repurposing" of existing therapies for indications of alternative disease is an attractive approach that can generate lower costs and require a shorter approval time than developing a de novo drug. The development of experimental dr...

Predicting Drug-Target Interactions with Deep-Embedding Learning of Graphs and Sequences.

The journal of physical chemistry. A
Computational approaches for predicting drug-target interactions (DTIs) play an important role in drug discovery since conventional screening experiments are time-consuming and expensive. In this study, we proposed end-to-end representation learning ...

Modern computational intelligence based drug repurposing for diabetes epidemic.

Diabetes & metabolic syndrome
BACKGROUND AND AIM: Objectives are to explore recent advances in discovery of new antidiabetic agents using repurposing strategies and to discuss modern technologies used for drug repurposing highlighting diabetic specific web portal.

Prediction of drug efficacy from transcriptional profiles with deep learning.

Nature biotechnology
Drug discovery focused on target proteins has been a successful strategy, but many diseases and biological processes lack obvious targets to enable such approaches. Here, to overcome this challenge, we describe a deep learning-based efficacy predicti...

Machine learning models to select potential inhibitors of acetylcholinesterase activity from SistematX: a natural products database.

Molecular diversity
Alzheimer's disease is the most common form of dementia, representing 60-70% of dementia cases. The enzyme acetylcholinesterase (AChE) cleaves the ester bonds in acetylcholine and plays an important role in the termination of acetylcholine activity a...

Combining generative artificial intelligence and on-chip synthesis for de novo drug design.

Science advances
Automating the molecular design-make-test-analyze cycle accelerates hit and lead finding for drug discovery. Using deep learning for molecular design and a microfluidics platform for on-chip chemical synthesis, liver X receptor (LXR) agonists were ge...

Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.

Molecular diversity
Artificial intelligence (AI) renders cutting-edge applications in diverse sectors of society. Due to substantial progress in high-performance computing, the development of superior algorithms, and the accumulation of huge biological and chemical data...